{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:33:27Z","timestamp":1792460007348,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.intimp.2025.114165","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T08:15:49Z","timestamp":1737965749000},"page":"114165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["SRF\/SLC31A1 signaling promotes cuproptosis induced by celastrol in NSCLC"],"prefix":"10.1016","volume":"148","author":[{"given":"Rui","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuling","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyue","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianning","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanjie","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyou","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.intimp.2025.114165_b0005","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.intimp.2025.114165_b0010","article-title":"Lung cancer trends and tumor characteristic changes over 20 years (2000-2020): results of three French consecutive nationwide prospective cohorts' studies","volume":"22","author":"Debieuvre","year":"2022","journal-title":"Lancet Reg. Health Eur."},{"issue":"2","key":"10.1016\/j.intimp.2025.114165_b0015","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3390\/ijms19020448","article-title":"Apoptosis: a target for anticancer therapy","volume":"19","author":"Pfeffer","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2025.114165_b0020","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrc776","article-title":"Death and anti-death: tumour resistance to apoptosis","volume":"2","author":"Igney","year":"2002","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"10.1016\/j.intimp.2025.114165_b0025","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.18632\/oncotarget.1944","article-title":"Novel combination of mitochondrial division inhibitor 1 (mdivi-1) and platinum agents produces synergistic pro-apoptotic effect in drug resistant tumor cells","volume":"5","author":"Qian","year":"2014","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.intimp.2025.114165_b0030","article-title":"Pathogenesis and therapeutic strategy in platinum resistance lung cancer","volume":"1876","author":"Lv","year":"2021","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.intimp.2025.114165_b0035","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","article-title":"Ferroptosis, a new form of cell death: opportunities and challenges in cancer","volume":"12","author":"Mou","year":"2019","journal-title":"J. Hematol. Oncol."},{"issue":"6586","key":"10.1016\/j.intimp.2025.114165_b0040","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.abf0529","article-title":"Copper induces cell death by targeting lipoylated TCA cycle proteins","volume":"375","author":"Tsvetkov","year":"2022","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.intimp.2025.114165_b0045","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12943-023-01732-y","article-title":"Cuproptosis: mechanisms and links with cancers","volume":"22","author":"Xie","year":"2023","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.intimp.2025.114165_b0050","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.3390\/ijms24021667","article-title":"ATF3\/SPI1\/SLC31A1 signaling promotes cuproptosis induced by advanced glycosylation end products in diabetic myocardial injury","volume":"24","author":"Huo","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"7\u20138","key":"10.1016\/j.intimp.2025.114165_b0055","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1080\/10937404.2010.538657","article-title":"An exposure-response curve for copper excess and deficiency","volume":"13","author":"Chambers","year":"2010","journal-title":"J. Toxicol. Environ. Health B Crit. Rev."},{"issue":"3","key":"10.1016\/j.intimp.2025.114165_b0060","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cmet.2006.08.009","article-title":"Ctr1 drives intestinal copper absorption and is essential for growth, iron metabolism, and neonatal cardiac function","volume":"4","author":"Nose","year":"2006","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.intimp.2025.114165_b0065","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.bcp.2010.04.030","article-title":"The role of the N-terminus of mammalian copper transporter 1 in the cellular accumulation of cisplatin","volume":"80","author":"Larson","year":"2010","journal-title":"Biochem. Pharmacol."},{"issue":"22","key":"10.1016\/j.intimp.2025.114165_b0070","doi-asserted-by":"crossref","first-page":"14298","DOI":"10.1073\/pnas.162491399","article-title":"Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals","volume":"99","author":"Ishida","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.intimp.2025.114165_b0075","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1124\/mol.111.076422","article-title":"Specificity protein 1 (sp1) oscillation is involved in copper homeostasis maintenance by regulating human high-affinity copper transporter 1 expression","volume":"81","author":"Liang","year":"2012","journal-title":"Mol. Pharmacol."},{"issue":"5","key":"10.1016\/j.intimp.2025.114165_b0080","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.cell.2007.08.021","article-title":"Molecular understanding and modern application of traditional medicines: triumphs and trials","volume":"130","author":"Corson","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2025.114165_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112081","article-title":"Celastrol: Progresses in structure-modifications, structure-activity relationships, pharmacology and toxicology","volume":"189","author":"Hou","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.intimp.2025.114165_b0090","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/jcmm.14805","article-title":"Celastrol exerts anti-inflammatory effect in liver fibrosis via activation of AMPK-SIRT3 signalling","volume":"24","author":"Wang","year":"2020","journal-title":"J. Cell Mol. Med."},{"issue":"4","key":"10.1016\/j.intimp.2025.114165_b0095","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.arcmed.2020.03.001","article-title":"Potential anticancer effect of celastrol on hepatocellular carcinoma by suppressing CXCR4-related signal and impeding tumor growth in vivo","volume":"51","author":"Kun-Ming","year":"2020","journal-title":"Arch. Med. Res."},{"issue":"5","key":"10.1016\/j.intimp.2025.114165_b0100","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.cell.2015.05.011","article-title":"Treatment of obesity with celastrol","volume":"161","author":"Liu","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2025.114165_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102134","article-title":"The Nrf2-NLRP3-caspase-1 axis mediates the neuroprotective effects of Celastrol in Parkinson's disease","volume":"47","author":"Zhang","year":"2021","journal-title":"Redox Biol."},{"issue":"22","key":"10.1016\/j.intimp.2025.114165_b0110","doi-asserted-by":"crossref","first-page":"10290","DOI":"10.7150\/thno.46728","article-title":"Celastrol induces ROS-mediated apoptosis via directly targeting peroxiredoxin-2 in gastric cancer cells","volume":"10","author":"Chen","year":"2020","journal-title":"Theranostics"},{"issue":"5","key":"10.1016\/j.intimp.2025.114165_b0115","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.tiv.2011.03.023","article-title":"Celastrol induces apoptosis in non-small-cell lung cancer A549 cells through activation of mitochondria- and Fas\/FasL-mediated pathways","volume":"25","author":"Mou","year":"2011","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.intimp.2025.114165_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.115075","article-title":"Celastrol augments sensitivity of NLRP3 to CP-456773 by modulating HSP-90 and inducing autophagy in dextran sodium sulphate-induced colitis in rats","volume":"400","author":"Saber","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.intimp.2025.114165_b0125","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejphar.2017.08.036","article-title":"A new mechanism of inhibition of IL-1\u03b2 secretion by celastrol through the NLRP3 inflammasome pathway","volume":"814","author":"Xin","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2025.114165_b0130","article-title":"Parabacteroides distasonis ameliorates hepatic fibrosis potentially via modulating intestinal bile acid metabolism and hepatocyte pyroptosis in male mice","volume":"14","author":"Zhao","year":"2023","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.intimp.2025.114165_b0135","article-title":"Mechanistic engineering of celastrol liposomes induces ferroptosis and apoptosis by directly targeting VDAC2 in hepatocellular carcinoma","volume":"18","author":"Luo","year":"2023","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.intimp.2025.114165_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116183","article-title":"Carrier-free self-assembled nanomedicine based on celastrol and galactose for targeting therapy of hepatocellular carcinoma via inducing ferroptosis","volume":"267","author":"Zhang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"22","key":"10.1016\/j.intimp.2025.114165_b0145","article-title":"Cuproptosis induced by ROS responsive nanoparticles with elesclomol and copper combined with \u03b1PD-L1 for enhanced cancer immunotherapy","volume":"35","author":"Guo","year":"2023","journal-title":"Adv. Mater."},{"issue":"10","key":"10.1016\/j.intimp.2025.114165_b0150","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s00424-020-02412-2","article-title":"The molecular mechanisms of copper metabolism and its roles in human diseases","volume":"472","author":"Chen","year":"2020","journal-title":"Pflugers Arch."},{"issue":"13","key":"10.1016\/j.intimp.2025.114165_b0155","article-title":"Stimulus-responsive copper complex nanoparticles induce cuproptosis for augmented cancer immunotherapy","volume":"11","author":"Hu","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.intimp.2025.114165_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.101018","article-title":"Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance","volume":"72","author":"Wang","year":"2024","journal-title":"Drug Resist. Updat."},{"issue":"4","key":"10.1016\/j.intimp.2025.114165_b0165","doi-asserted-by":"crossref","first-page":"972","DOI":"10.3390\/nu15040972","article-title":"Copper induces cognitive impairment in mice via modulation of cuproptosis and CREB signaling","volume":"15","author":"Zhang","year":"2023","journal-title":"Nutrients"},{"issue":"8","key":"10.1016\/j.intimp.2025.114165_b0170","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","article-title":"Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy","volume":"12","author":"Koppula","year":"2021","journal-title":"Protein Cell"},{"issue":"43","key":"10.1016\/j.intimp.2025.114165_b0175","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202204733","article-title":"An enzyme-engineered nonporous copper(I) coordination polymer nanoplatform for cuproptosis-based synergistic cancer therapy","volume":"34","author":"Xu","year":"2022","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.intimp.2025.114165_b0180","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.canlet.2010.08.002","article-title":"Nuclear factor-\u03baB modulates cellular glutathione and prevents oxidative stress in cancer cells","volume":"299","author":"Meng","year":"2010","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2025.114165_b0185","article-title":"Glutathione-scavenging celastrol-Cu nanoparticles induce self-amplified cuproptosis for augmented cancer immunotherapy","author":"Lu","year":"2024","journal-title":"Adv. Mater."},{"issue":"11","key":"10.1016\/j.intimp.2025.114165_b0190","doi-asserted-by":"crossref","first-page":"10206","DOI":"10.1021\/acsnano.3c00326","article-title":"Type-I AIE photosensitizer loaded biomimetic system boosting cuproptosis to inhibit breast cancer metastasis and rechallenge","volume":"17","author":"Ning","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.intimp.2025.114165_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122675","article-title":"In situ hydrogel based on Cu-Fe(3)O(4) nanoclusters exploits oxidative stress and the ferroptosis\/cuproptosis pathway for chemodynamic therapy","volume":"311","author":"Zhang","year":"2024","journal-title":"Biomaterials"},{"key":"10.1016\/j.intimp.2025.114165_b0200","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.actbio.2024.05.035","article-title":"Dendrimer\/metal-phenolic nanocomplexes encapsulating CuO(2) for targeted magnetic resonance imaging and enhanced ferroptosis\/cuproptosis\/chemodynamic therapy by regulating the tumor microenvironment","volume":"183","author":"Huang","year":"2024","journal-title":"Acta Biomater."},{"key":"10.1016\/j.intimp.2025.114165_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122701","article-title":"A strategy of \u201cadding fuel to the flames\u201d enables a self-accelerating cycle of ferroptosis-cuproptosis for potent antitumor therapy","volume":"311","author":"Huang","year":"2024","journal-title":"Biomaterials"},{"key":"10.1016\/j.intimp.2025.114165_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111381","article-title":"Traditional Chinese medicine and lung cancer\u2013From theory to practice","volume":"137","author":"Li","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2025.114165_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114882","article-title":"Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies","volume":"163","author":"Wang","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"8","key":"10.1016\/j.intimp.2025.114165_b0220","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1002\/1878-0261.12936","article-title":"Ferroptosis inducer erastin sensitizes NSCLC cells to celastrol through activation of the ROS-mitochondrial fission-mitophagy axis","volume":"15","author":"Liu","year":"2021","journal-title":"Mol. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2025.114165_b0225","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-022-03741-9","article-title":"Celastrol elicits antitumor effects by inhibiting the STAT3 pathway through ROS accumulation in non-small cell lung cancer","volume":"20","author":"Zhao","year":"2022","journal-title":"J. Transl. Med."},{"issue":"3","key":"10.1016\/j.intimp.2025.114165_b0230","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.joim.2024.03.007","article-title":"Ferroptosis inhibitors reduce celastrol toxicity and preserve its insulin sensitizing effects in insulin resistant HepG2 cells","volume":"22","author":"Liu","year":"2024","journal-title":"J Integr Med"},{"issue":"38","key":"10.1016\/j.intimp.2025.114165_b0235","doi-asserted-by":"crossref","first-page":"E2523","DOI":"10.1073\/pnas.1208141109","article-title":"Serum Response Factor (SRF)-cofilin-actin signaling axis modulates mitochondrial dynamics","volume":"109","author":"Beck","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2025.114165_b0240","doi-asserted-by":"crossref","unstructured":"T. Walker, A. Nolte, V. Steger, C. Makowiecki, M. Mustafi, G. Friedel, C. Schlensak, H.P. Wendel, Small interfering RNA-mediated suppression of serum response factor, E2-promotor binding factor and survivin in non-small cell lung cancer cell lines by non-viral transfection, Eur. J. Cardiothorac. Surg. 43(3) (2013) 628-633; discussion 633-624.","DOI":"10.1093\/ejcts\/ezs337"},{"issue":"2","key":"10.1016\/j.intimp.2025.114165_b0245","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3892\/ijo.2015.3034","article-title":"SRF-miR\u201129b-MMP2 axis inhibits NSCLC invasion and metastasis","volume":"47","author":"Wang","year":"2015","journal-title":"Int. J. Oncol."},{"issue":"38","key":"10.1016\/j.intimp.2025.114165_b0250","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202003451","article-title":"An activatable nano-prodrug for treating tyrosine-kinase-inhibitor-resistant non-small cell lung cancer and for optoacoustic and fluorescent imaging","volume":"16","author":"Xie","year":"2020","journal-title":"Small"},{"key":"10.1016\/j.intimp.2025.114165_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114705","article-title":"A comprehensive review on celastrol, triptolide and triptonide: Insights on their pharmacological activity, toxicity, combination therapy, new dosage form and novel drug delivery routes","volume":"162","author":"Song","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"28","key":"10.1016\/j.intimp.2025.114165_b0260","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adn0960","article-title":"Prodrug-inspired adenosine triphosphate-activatable celastrol-Fe(III) chelate for cancer therapy","volume":"10","author":"Li","year":"2024","journal-title":"Sci. Adv."},{"issue":"35","key":"10.1016\/j.intimp.2025.114165_b0265","doi-asserted-by":"crossref","first-page":"18463","DOI":"10.1039\/D0NR01066A","article-title":"Hydrogel-mediated delivery of celastrol and doxorubicin induces a synergistic effect on tumor regression via upregulation of ceramides","volume":"12","author":"Medatwal","year":"2020","journal-title":"Nanoscale"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925001547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925001547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T01:01:03Z","timestamp":1740618063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925001547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":53,"alternative-id":["S1567576925001547"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114165","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SRF\/SLC31A1 signaling promotes cuproptosis induced by celastrol in NSCLC","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114165","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114165"}}